TrialsgrambetaRCTs are beautiful

CABANA

2019

Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation

In 2,204 patients with symptomatic atrial fibrillation, catheter ablation did not significantly reduce death, disabling stroke, serious bleeding, or cardiac arrest compared with antiarrhythmic drug therapy.

Result

Efficacy: Composite of death, disabling stroke, serious bleeding, or cardiac arrestHR 0.86 (95% CI 0.65-1.15) · P = 0.30

Below 1 favours catheter ablation, above 1 favours antiarrhythmic drug therapy.

Event rates
Absolute difference
1.2 points

The absolute difference is derived from the event rates.

Also reported: Neutral by intention-to-treat. Per-protocol and as-treated analyses favoured ablation.

Original publication
Subtopic
Ablation
Design
Open-label multicentre RCT
Relevance
Important: one of several pillars.
Source
Packer DL, et al. JAMA. 2019;321(13):1261-1274.doi 10.1001/jama.2019.0693

Discussion & critique

Substantial crossover between arms diluted the intention-to-treat comparison. Although the primary endpoint was neutral, ablation improved quality of life and became reasonable first-line rhythm control for symptomatic AF.

Discussed in podcasts